Although PBV is the treatment of choice for native MV stenosis due to commissural fusion, reports of valvuloplasty for bioprosthetic MV stenosis are rare and there is equipoise toward its efficacy and safety
Although PBV is the treatment of choice for native MV stenosis due to commissural fusion, reports of valvuloplasty for bioprosthetic MV stenosis are rare and there is equipoise toward its efficacy and safety (1-3). Ours appears to be the first reported case performed using both 3D TEE guidance and fluoroscopy.
This case demonstrates the utility of PBV for prosthetic stenosis due to leaflet fusion, perhaps as an option for temporary palliation of symptoms in patients with a high surgical risk or those awaiting a more definitive treatment such as transcatheter ViV implantation (4). 
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Manuscript received November 13, 2015; accepted November 19, 2015. valve area from 0.6 to 1.5 cm 2 (E, Online Video 1E) and a marked improvement in mitral valve gradient from 16 to 6 mm Hg (F). 
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